FINWIRES · TerminalLIVE
FINWIRES

$AVCR.V

2 stories mentioning AVCR.VUpdated 34d ago

Every FINWIRES story that references AVCR.V, newest first.

Mining & Metals

Avricore Health Announces $1.25 Million Financing

Avricore Health (AVCR.V) announced Wednesday a non-brokered private placement of up to 25 million units at a price of $0.05 each for gross proceeds of $1.25 million.Each unit consists of one common share and one half transferrable share purchase warrant, said the company and added that each warrant will entitle the holder to purchase one additional common share for a period of 24 months from the closing date of the offering at a price of $0.10 per common share.Certain directors and officers are expected to participate in the private placement, added the company.The proceeds will be used to expand the company's HealthTab network and for general working capital purposes.Closing of the private placement is subject to acceptance by the TSX Venture Exchange.

$AVCR.V
Mining & Metals

Avricore Health Outlines UK Expansion Roadmap for HealthTab Platform

Avricore Health (AVCR.V) said Tuesday that its HealthTab platform has now screened more than 3,500 patients in community pharmacies across North East and North Central London.The company also updated its expansion strategy for its HealthTab point-of-care testing platform in the UK. HealthTab launched HbA1c testing for diabetes screening in the first quarter of this year, and UACR kidney function testing is planned for the third quarter of this year. During an initial one-month pilot of HbA1c testing, the company completed 2,295 HbA1c tests for diabetes across 57 locations, a statement said.Avricore expects its current pilots to expand to more than 100 pharmacy sites in the second quarter, with monthly subscription revenue expected to begin in the second half of 2026.The company, which is targeting 500 or more active UK locations by mid-2027, is forecasting a return to profitability by the third quarter of next year.It noted that from September, all newly qualified pharmacists in England will graduate as independent prescribers, which will strengthen the clinical role of community pharmacy and supports the broader adoption of point-of-care testing infrastructure such as HealthTab.Avricore shares closed unchanged at $0.065, on the TSX Venture Exchange on Monday.

$AVCR.V

Track with the FINWIRES app suite

FolioX
FolioX
Track AVCR.V in your portfolio
WheelAI
WheelAI
Analyze AVCR.V options with the wheel strategy
StockInsider
StockInsider
See market sentiment on AVCR.V